Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02207075 : Measuring Active Microglia in Progressive Multiple Sclerosis
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- Subjects age 18-80

- Secondary progressive MS subjects either untreated or on consistent treatment for
six-months prior to enrollment

- Norman Controls

Exclusion Criteria:

- Subjects pregnant or woman of child-bearing age not utilizing effective birth control

- Primary progressive MS subjects

- Relapsing remitting MS subjects

- Unstable SPMS subject for which treatment change within the 24 months is likely

Age-Healthy controls will be excluded if have any of the following medical conditions:

- Any central nervous system disorder

- Any systemic auto-immune disorder

- Pregnant or woman of child-bearing age not utilizing effective birth control

Subjects will be withdrawn from the study if treatment is changed during the 24-month
study
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02207075      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740